DrugPatentWatch

DrugPatentWatch Archives

You are currently viewing the 2008 archives
Click here to return to the current data set

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Generic Name: ibandronate sodium

Summary for Generic Name: ibandronate sodium

Tradenames:1
Patents:6
Applicants:1
NDAs:2
Drug Master File Entries: see list16
Suppliers: see list2
Therapeutic Class:Metabolic Bone Disease Agents
Formulation / Manufacturing:see details

Pharmacology for Ingredient: ibandronate sodium

Ingredient-typeDiphosphonates
Drug ClassBisphosphonate

Tentative approvals for IBANDRONATE SODIUM

Applicant Application No. Form Dosage
<disabled><disabled>TABLET; ORAL2.5MG
<disabled><disabled>INJECTABLE; INJECTION1MG

Clinical Trials for: ibandronate sodium

BONVIVA(Ibandronate) PMS(Post-marketing Surveillance )
Status: Completed Condition: Osteoporosis

Study Comparing Ibandronate Versus Placebo in Hip Osteonecrosis
Status: Not yet recruiting Condition: Aseptic;; Hip Necrosis

Bioequivalence Study of Ibandronate Sodium Tablets 150 mg Under Fasting Condition
Status: Completed Condition: Healthy

BONVIVA(Ibandronate) Injection PMS(Post-marketing Surveillance)
Status: Completed Condition: Osteoporosis

Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis
Status: Completed Condition: Postmenopausal Osteoporosis

PTH & Ibandronate Combination Study (PICS)
Status: Completed Condition: Osteoporosis

Courtesy of ClinicalTrials.org
See more clinical trials for this drug

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Patented / Exclusive Use
Roche
BONIVA
ibandronate sodium
INJECTABLE; INTRAVENOUS021858Jan 6, 2006RXYes<disabled>NEW CHEMICAL ENTITY
Roche
BONIVA
ibandronate sodium
INJECTABLE; INTRAVENOUS021858Jan 6, 2006RXYes<disabled>NEW DOSAGE FORM
Roche
BONIVA
ibandronate sodium
INJECTABLE; INTRAVENOUS021858Jan 6, 2006RXYes4,927,814<disabled>TREATMENT AND PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
Roche
BONIVA
ibandronate sodium
INJECTABLE; INTRAVENOUS021858Jan 6, 2006RXYes5,662,918<disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc